Risk factors for vitamin D deficiency in HIV-infected patients in the South Central United States

AIDS Research and Human Retroviruses

Volumn 28, Issue 5, 2012, Pages 454-459

  Crutchley, Rustin D ^a,b   Gathe, Joseph ^b   Mayberry, Carl ^b   Trieu, Angel ^a   Abughosh, Susan ^a   Garey, Kevin W ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b Therapeutic Concepts Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; VITAMIN D;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; DIET; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPOSURE; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PRIVATE PRACTICE; RACE DIFFERENCE; RISK FACTOR; SMOKING HABIT; SUNLIGHT; UNITED STATES; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84860433261     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0025     Document Type: Article

References (43)

1. Holick MF: Vitamin D deficiency. N Engl J Med 2007;357: 266-281.
2. Melamed ML, Michos ED, Post W, and Astor B: 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168(15):1629-1637.
3. DeLuca HF and Cantorna MT: Vitamin D: its role and uses in immunology. FASEB J 2001;15:2579-2585. (Pubitemid 33131084)
4. Nemere I and Farach-Carson MC: Membrane receptors for steroid hormones: A case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem Biophys Res Commun 1998;248:442-449.
5. Zitterman A: Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552-572.
6. Norman AW: Receptors for 1a-25(OH)2D3: Past, present and future. J Bone Mineral Res 1998;13:1360-1369.
7. NietoG, BarberY, RubioMC, RubioM, and Fibla J:Association between AIDS disease progression rates and the Fok-I polymorphism of the VDR gene in a cohort of HIV-1 seropositive patients. J Steroid Biochem Mol Biol 2004;89-90:199-207. (Pubitemid 38844283)
8. Cannell JJ and Hollis BW: Use of vitamin D in clinical practice. Altern Med Rev 2008;13(1):6-20. (Pubitemid 351489580)
9. Autier P and Gandini S: Vitamin D supplementation and total mortality: A meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-1737. (Pubitemid 47403059)
10. Perez-Castrillon JL, Vega G, Abad L, et al.: Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007;99:903-905. (Pubitemid 46483276)
11. Aloia JF, Li-Ng M, and Pollack S: Statins and vitamin D. Am J Cardiol 2007;100:1329. (Pubitemid 47498272)
12. Pittas AG, Chung M, Trikalinos T, et al.: Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-314.
13. Wang L, Manson JE, Song Y, and Sesso HD: Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010;152:315-323.
14. Mehta S, Giovannucci E, Mugusi FM, et al.: Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PloSOne 2010;5(1):1-7.
15. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al.: Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. ADS Res Hum Retroviruses 2008;24(11):1375-1382.
16. Rodriguez M, Daniels B, Gunawardene S, and Robbins GK: High frequency of vitamin D deficiency in ambulatory HIVpositive patients. AIDS Res Hum Retroviruses 2009;25(1):9-14.
17. Welz T, Childs K, Ibrahim F, et al.: Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010;24:1923-1928.
18. Mueller NJ, Fux CA, Ledergerber B, et al.: High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naïve and successfully treated Swiss HIV patients. AIDS 2010;24:1127-1134.
19. Adeyemi OM, Agniel D, French AL, et al.: High rates of vitamin D deficiency among HIV-infected and at-risk women in the United States. 18th International AIDS Conference. WEPDB101 abstract.
20. Chien C, Carlotti C, Bhatti L, et al.: High prevalence of vitamin D deficiency among HIV-infected patients. 18th International AIDS Conference. WEPDB102 abstract.
21. Gandhi V, Kim JH, Psevdos G, Epsinoza F, Park J, and Sharp V: Evaluation of vitamin D levels in HIV-infected patients at the Center for Comprehensive Care, St. Luke's-Roosevelt Hospital Center, NY, USA. 18th International AIDS Conference. WEPDB104 abstract.
22. Rashid T, Devitt E, Mandalia S, et al.: No association of vitamin D levels with individual antiretroviral agents, duration of HIV infection, alkaline phosphatase levels nor bone mineral density findings. 18th International AIDS Conference. WEPDB105 abstract.
23. Pocaterra D, Ricci E, Carenzi L, et al.: Prevalence of hypovitaminosis D and factors associated in a sample of HIV patients. 18th International AIDS Conference. WEPDB106 abstract.
24. Wasserman P and Rubin DS: Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIVinfected men under care. AIDS Patient Care STDs 2010;24(4): 223-227.
25. Paul TV, Asha HS, Thomas N, et al.: Hypovitaminosis D and bone mineral density in human immunodeficiency virusinfected men from India, with or without antiretroviral therapy. Endocr Pract 2010;16:547-553.
26. Conesa-Botella A, Florence E, Lynen L, Colebunders R, Menten J, and Mareno-Reyes R: Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther 2010;7(40):1-6.
27. U.S. Department of Agriculture, Agricultural Research Service: USDA Nutrient Database for Standard Reference, Release 22, 2009.
28. Holick MF: McCollum Award Lecture, Vitamin D: New horizons for the 21st century. Am J Clin Nutr 1994;60:619-630.
29. Holick MF: Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062-2072. (Pubitemid 44162310)
30. Willis CM, Laing EM, Hall DB, Hausman DB, and Lewis RD: A prospective analysis of plasma 25-hydroxyvitamin D concentrations in white and black prepubertal females in the southeastern United States. Am J Clin Nutr 2007;85:124-130. (Pubitemid 46067625)
31. Wortsman J, Matsuoka LY, Chen TC, Lu Z, and Holick MF: Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693. (Pubitemid 30667088)
32. Yanoff LB, Parikh SJ, Spitalnik A, et al.: The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese black Americans. Clin Endocrinol 2006;64:523-529.
33. Alemzadeh R, Kichler J, Babar G, and Calhoun M: Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metab Clin Exp 2008;57:183-191.
34. Hypponen E and Power C: Vitamin D status and glucose homeostasis in the 1958 British birth cohort: The role of obesity. Diabetes Care 2006;29:2244-2246. (Pubitemid 44899859)
35. Snijder MB, van Dam RM, Visser M, et al.: Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005;90:4119-4123. (Pubitemid 41058184)
36. Chiu KC, Chu A, Go VL, and Saad MF: Hypovitaminosis D is associated with insulin resistance and B-cell dysfunction. Am J Clin Nutr 2004;79:820-825. (Pubitemid 41103882)
37. Stein EM, Yin MT, McMahon DJ, et al.: Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African American women. Osteoporos Int 2010;21(6):1299-1309.
38. Institute of Medicine, Food and Nutrition Board: Dietary Reference Intakes for Vitamin D and Calcium. National Academy Press, Washington, DC, 2010.
39. Ellfolk M, Norlin M, Gyllensten K, and Wikvall K: Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells. Mol Pharmacol 2009;75:1392-1399.
40. Pascussi JM, Robert A, Nguyen M, et al.: Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115:177-186. (Pubitemid 40385519)
41. Zhou C, Assem M, Tay JC, et al.: Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006;116(6):1703-1712.
42. Bolland MJ, Grey A, Horne AM, and Thomas MG: Osteomalacia in an HIV-infected man receiving rifabutin, a cytochrome P450 enzyme inducer: A case report. Ann Clin Microbiol Antimicrob 2008;7(3):1-5.
43. McCarty CA: Sunlight exposure assessment: can we accurately assess vitamin D exposure from sunlight questionnaires? Am J Clin Nutr 2008;87(Suppl):1097S-1101S. (Pubitemid 351549270)